Hatch, Guy M.
Ashbrook, Liza
Prather, Aric A.
Krystal, Andrew D. http://orcid.org/0000-0002-6702-781X
Funding for this research was provided by:
Reveal Biosensors Inc. (Reveal Biosensors, Inc.)
Article History
Received: 21 December 2019
Revised: 22 April 2020
Accepted: 7 May 2020
First Online: 26 May 2020
Compliance with ethical standards
:
: Guy Hatch: financial support–None; off-label/investigational use—cellular energy monitoring is not FDA approved and is investigational. Conflict of interest—co-founder and chief technology officer of Reveal Biosensors, Inc. Liza Ashbrook: financial support-none; off-label/investigational use—cellular energy monitoring is not FDA approved and is investigational. Conflict of interest—none. Aric Prather: financial support-research support from NIH, Headspace, Inc.; off-label/investigational use—cellular energy monitoring is not FDA approved and is investigational. Conflict of interest—none. Andrew Krystal: financial support-research support from Reveal Biosensors; off-label/investigational use—cellular energy Monitoring is not FDA approved and is investigational. Conflict of interest—research support from NIH, Janssen, Jazz. Axsome, Reveal Biosensors; consultant to Adare, Eisai, Ferring, Galderma, Harmony Biosciences, Idorsia, Jazz, Janssen, Takeda, Merck, Neurocrine, Pernix, Physician’s Seal, Evecxia, Sage.
: All procedures performed in this study were in accordance with the ethical standards of the UCSF IRB and with the 1964 Helsinki declaration and its later amendments. Approval for carrying out this study was obtained from the UCSF IRB. This article does not contain any studies with animals performed by any of the authors.
: All persons participating in this study gave their informed consent prior to their inclusion in the study.